The effect of menaquinone-7 supplementation on dp-ucMGP, PIVKAII, inflammatory markers, and body composition in type 2 diabetes patients: a randomized clinical trial.
- 2022-04-01
- RCT · n = 45
- Nutrition & diabetes 12(1)
- Nahid Karamzad
- Esmaeil Faraji
- Shaghayegh Adeli
- Mark J M Sullman
- Bahram Pourghassem Gargari
- PubMed: 35365594
- DOI: 10.1038/s41387-022-00192-5
- High evidence
- Clinical
The body composition indices (i.e., body fat percentage, fat mass, fat free mass, muscle mass, bone mass and total body water) were not significantly different between groups or across the trial.
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 200 mcg/day